Central precocious puberty: an Endocrine Society clinical practice guideline

医学 指南 社会心理的 临床实习 小心等待 儿科 分级(工程) 多学科方法 重症监护医学 心理干预 梅德林 系统回顾 内分泌系统 妇科 家庭医学 生殖健康 不利影响 性早熟 疾病 利益相关者 多学科团队
作者
Ana Cláudia Latronico,Stephanie A. Roberts,Morgan Alonzo,Jesús Argente,Ana Pinheiro Machado Canton,Jean‐Claude Carel,FERNANDO G. CASSORLA,Evangelia Charmandari,Erica A. Eugster,Anna Grandone,Louise C. Greenspan,Elizabeth C Hawse,Anders Juul,Paul B. Kaplowitz,M Hassan Murad,Maria Elisabeth Street,Vayana Walker,Christopher Rolland McCartney
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
卷期号:111 (8): 2101-2144 被引量:28
标识
DOI:10.1210/clinem/dgag168
摘要

BACKGROUND: Central precocious puberty (CPP), which is traditionally defined as the development of secondary sexual characteristics before age 8 years in girls and age 9 years in boys, results from the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis. CPP can be associated with short adult stature, adverse psychosocial outcomes, and increased cardiometabolic and cancer risks in adulthood. Gonadotropin-releasing hormone (GnRH) agonists can effectively suppress premature activation of the HPG axis and have the potential to increase adult height as well as improve psychosocial and long-term health outcomes among patients with CPP. However, as secular trends have continued to shift toward earlier age of pubertal onset, some subpopulations of children with CPP, as it is currently defined, may not require the same extent of diagnostic evaluation and treatment. OBJECTIVE: Develop evidence-based recommendations related to the diagnosis and treatment of CPP. METHODS: A multidisciplinary panel of clinical experts, along with experts in guideline methodology and systematic literature review, used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to address 10 clinical questions related to the diagnosis and treatment of CPP. Systematic reviews of health-related benefits and harms were conducted for each clinical question. The guideline development panel (GDP) also used the GRADE evidence-to-decision (EtD) framework to address stakeholder values and preferences, costs and required resources, cost-effectiveness, acceptability, feasibility, and potential impacts on health equity. RESULTS: In girls with thelarche (Tanner stage B2) between ages 7.0 and 8.0 years, the GDP suggests watchful waiting via periodic physical examinations (every 4-6 months) rather than immediately performing evaluation with laboratory testing or radiologic imaging. In addition, the GDP suggests that all girls with breast development (ie, Tanner stage B2) before age 7 years should first be observed for 4 to 6 months to differentiate unsustained or slowly progressive puberty vs rapidly progressive puberty. These recommendations are largely based on evidence that girls with slowly progressive puberty attain a normal adult height without treatment. When hormonal evaluation is performed to confirm central (GnRH-dependent) activation as the cause of precocious puberty, the GDP suggests starting the evaluation with ultrasensitive basal luteinizing hormone (LH) concentration rather than routine GnRH/GnRH agonist (GnRHa) stimulation testing for all patients. While brain magnetic resonance imaging has been a traditional part of CPP evaluation, the GDP suggests that it should not be routinely performed in girls ages 6.0 to 8.0 years and boys ages 8.0 to 9.0 years without central nervous system (eg, neuro-ophthalmologic) symptoms, largely based on a low prevalence of pathologic intracranial findings in these age groups. The GDP suggests against routine genetic testing for patients with CPP, although they judged that genetic testing (eg, MKRN3 sequencing) should be considered for patients with familial CPP through a shared decision-making process. The GDP suggests GnRHa treatment for many children with CPP, although available evidence suggests that some patient subgroups (eg, older girls with slowly progressive CPP) may be less likely to receive a net benefit with this treatment. Rather than always starting GnRHa treatment with a monthly injectable formulation, the GDP suggests that treatment should be initiated with the formulation (such as a longer-acting formulation) that is anticipated to be used long-term. The GDP suggests against routine addition of growth hormone therapy to increase adult height. They also suggest against the routine biochemical testing (eg, LH, sex steroids) to monitor pubertal suppression while receiving GnRHa, instead reserving biochemical testing to confirm clinically suspected treatment failure. Finally, the GDP suggests against routinely continuing GnRHa treatment beyond chronologic age 10.0 to 11.0 years (girls) or 11.0 to 12.0 years (boys) and/or bone age 11.0 to 12.0 years (girls) or 12.0 to 13.0 years (boys). CONCLUSION: These clinical recommendations were developed to address important uncertainties in the diagnosis and treatment of children with CPP. They are based on the best available scientific evidence regarding clinical outcomes judged to be most important to patients and families. The GDP's overarching goal was to suggest diagnostic and therapeutic strategies that will most likely provide net clinical benefits while simultaneously considering important contextual factors such as cost and feasibility. The guideline-development process highlighted important knowledge gaps and the substantial need for additional research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
bulabulabu发布了新的文献求助10
刚刚
海底捞不动完成签到 ,获得积分10
刚刚
SciGPT的应助被甜甜的悲采纳,获得10
1秒前
清风完成签到,获得积分10
1秒前
2秒前
Akim的应助被大坤坤采纳,获得10
2秒前
2秒前
汉堡包的应助被qs采纳,获得10
4秒前
yjw0526发布了新的文献求助10
4秒前
默默初阳的应助被纯真若云采纳,获得20
4秒前
Leo发布了新的文献求助10
5秒前
海底捞不动关注了科研通微信公众号
5秒前
Ziezer发布了新的文献求助10
5秒前
6秒前
6秒前
丘比特的应助被两碗牛又面采纳,获得10
7秒前
66666完成签到,获得积分10
7秒前
upup完成签到,获得积分10
7秒前
懒狼狼的应助被王昊采纳,获得10
7秒前
7秒前
未炙完成签到 ,获得积分10
8秒前
8秒前
stone完成签到,获得积分10
9秒前
DYF发布了新的文献求助20
9秒前
10秒前
Owen的应助被勤奋柜子采纳,获得10
10秒前
清风完成签到,获得积分10
10秒前
嘟嘟发布了新的文献求助10
11秒前
11秒前
张兵发布了新的文献求助10
11秒前
既白完成签到,获得积分10
11秒前
11秒前
labor的应助被暮冬贰拾玖采纳,获得10
11秒前
12秒前
12秒前
儒雅的凝旋完成签到,获得积分10
13秒前
13秒前
完美世界的应助被时尚的雅柏采纳,获得10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178203
求助须知:如何正确求助?哪些是违规求助? 9568998
关于积分的说明 21802098
捐赠科研通 7773088
什么是DOI,文献DOI怎么找? 3432711
关于科研通互助平台的介绍 2556748
邀请新用户注册赠送积分活动 2478259